Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179572 | SCV000231837 | pathogenic | not provided | 2014-11-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000792250 | SCV000931531 | pathogenic | Retinitis pigmentosa 12; Leber congenital amaurosis 8 | 2024-01-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg526*) in the CRB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CRB1 are known to be pathogenic (PMID: 10508521, 22065545, 23379534, 25412400, 26957898, 28041643, 29391521). This variant is present in population databases (rs114342808, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with CRB1-related conditions (PMID: 18682808, 23462753, 28512305). ClinVar contains an entry for this variant (Variation ID: 143167). For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV001073589 | SCV001239140 | pathogenic | Retinal dystrophy | 2019-07-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000179572 | SCV004025556 | pathogenic | not provided | 2023-08-07 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 23462753, 25324289, 32351147, 31054281, 20981092, 18682808, 32165824, 31456290, 33090715, 32901917, 33342761, 33946315, 34721897, 22344438, 25133751, 25445212, 28512305, 20956273, 23449718, 24715753, 29145603, 31630094) |
Genome- |
RCV000132698 | SCV004179943 | pathogenic | Leber congenital amaurosis 8 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453099 | SCV004179944 | pathogenic | Pigmented paravenous retinochoroidal atrophy | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453098 | SCV004179945 | pathogenic | Retinitis pigmentosa 12 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000132698 | SCV004211111 | pathogenic | Leber congenital amaurosis 8 | 2024-03-28 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV001073589 | SCV004705074 | pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Department of Ophthalmology and Visual Sciences Kyoto University | RCV000132698 | SCV000172651 | pathogenic | Leber congenital amaurosis 8 | no assertion criteria provided | not provided | Converted during submission to Pathogenic. | |
Molecular Diagnostics Laboratory, |
RCV000132698 | SCV000189601 | pathogenic | Leber congenital amaurosis 8 | 2014-09-18 | no assertion criteria provided | clinical testing | |
Sharon lab, |
RCV001002990 | SCV001161044 | pathogenic | Leber congenital amaurosis | 2019-06-23 | no assertion criteria provided | research | |
Natera, |
RCV001002990 | SCV002090142 | pathogenic | Leber congenital amaurosis | 2020-08-17 | no assertion criteria provided | clinical testing |